x

Search for a clinical trial

* (*) mandatory field

54 Result(s)

Sort by

Recruiting trial = Recruiting trial
; Ongoing trial = Ongoing trial
; Funded by an IRDiRC member =

National clinical trial(s)

AUSTRIA

WIEN
WIEN

Recruiting trial
Ongoing trial
High Risk Neuroblastoma Study 1 of SIOP-Europe (SIOPEN) (Phase III) - AT
St. Anna Kinderspital
Zentrum für Kinder- und Jugendheilkunde

AUSTRIA

WIEN
WIEN

Recruiting trial
Ongoing trial
LINES: European Low and Intermediate Risk Neuroblastoma Protocol (Phase III) - AT
St. Anna Kinderspital
Zentrum für Kinder- und Jugendheilkunde

FRANCE

ILE-DE-FRANCE
VILLEJUIF

Phase 2 single-arm study of gemcitabine in combination with oxaliplatin in refractory and relapsed pediatric solid tumors - Terminated -
CLCC Institut Gustave Roussy
Département de cancérologie de l'enfant et de l'adolescent

FRANCE

ILE-DE-FRANCE
VILLEJUIF

FRANCE

PROVENCE-ALPES-COTE D'AZUR
MARSEILLE

GERMANY

Mecklenburg-Vorpommern
GREIFSWALD

GERMANY

Nordrhein-Westfalen
KÖLN

GERMANY

Nordrhein-Westfalen
MÜNSTER

Doxo: Phase II pharmacokinetic study to assess the age-dependency in the clearance of Doxorubicin in paediatric patients with Solid Tumours and Leukaemia - DE - Completed
Universitätsklinikum Münster
Klinik für Kinder- und Jugendmedizin - Pädiatrische Hämatologie und Onkologie

IRELAND

County Dublin
DUBLIN

European Infant Neuroblastoma Study Final Protocol (Phase III) - IE
Our Lady's Children's Hospital
National Oncology/ Bone Marrow Transplant Centre and Haematology Department

IRELAND

County Dublin
DUBLIN

Management of Children Aged Less Than 3 Years With Brain Tumors (Phase II) - IE
Our Lady's Children's Hospital
National Oncology/ Bone Marrow Transplant Centre and Haematology Department

IRELAND

County Dublin
DUBLIN

Phase II Study of Temozolomide (Temodal) in Children Over 1 Year of Age With Relapsed or Refractory High Risk Neuroblastoma - IE
Our Lady's Children's Hospital
National Oncology/ Bone Marrow Transplant Centre and Haematology Department

IRELAND

County Dublin
DUBLIN

Phase II Trial of Surgery as the Only Treatment for INSS Stage 2A & 2B Neuroblastoma - IE
Our Lady's Children's Hospital
National Oncology/ Bone Marrow Transplant Centre and Haematology Department

IRELAND

County Dublin
DUBLIN

NETHERLANDS

Noord-Holland
AMSTERDAM

Ongoing trial
Surgery in Treating Patients With Neuroblastoma
AMC - Academisch Medisch Centrum
Polikliniek Kinderoncologie

SPAIN

Comunidad Valenciana
VALENCIA

Recruiting trial
High Risk Neuroblastoma Study 1 Of Siop-Europe (Phase III) - ES
IIS La Fe - Instituto de Investigación Sanitaria La Fe
Grupo de Investigación Clínica y Traslacional en Cáncer

SPAIN

Comunidad Valenciana
VALENCIA

SPAIN

Comunidad Valenciana
VALENCIA

Recruiting trial
Ongoing trial
European Low and Intermediate Risk Neuroblastoma Protocol (Phase III) - ES
IIS La Fe - Instituto de Investigación Sanitaria La Fe
Grupo de Investigación Clínica y Traslacional en Cáncer

SPAIN

Comunidad Valenciana
VALENCIA

Recruiting trial
Ongoing trial
BEACON-Neuroblastoma Trial: A randomised phase IIb trial of bevacizumab added to temozolomide ± irinotecan for children with refractory/relapsed neuroblastoma - ES
IIS La Fe - Instituto de Investigación Sanitaria La Fe
Grupo de Investigación Clínica y Traslacional en Cáncer

UNITED KINGDOM

Greater London
LONDON

UNITED KINGDOM

Greater London
LONDON

Recruiting trial
Ongoing trial
NB 2002 06: High Risk Neuroblastoma Study 1 Of Siop-Europe (Phase III) - UK
Great Ormond Street Hospital for Children, NHS Foundation Trust
The Somers Clinical Research Facility Level 1

UNITED KINGDOM

Greater Manchester
MANCHESTER

UNITED KINGDOM

Surrey
SUTTON

UNITED KINGDOM

Tyne & Wear
NEWCASTLE UPON TYNE

Phase II pharmacokinetic study to assess the age-dependency in the clearance of Doxorubicin in paediatric patients with Solid Tumours and Leukaemia - UK
Northern Institute for Cancer Research, Medical School, Newcastle University
Northern Institute for Cancer Research

GERMANY

Hamburg
HAMBURG

UNITED KINGDOM

Greater Manchester
NOT YET IDENTIFIED - UK